Collaborative governance in higher-education residential centers: An exploratory mixed-methods study on character development potential
Estudios sobre Educación · 13.05.2026
DOI: 10.15581/004.52.004 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift Estudios sobre Educación, online erschienen am 13.05.2026. Verfasst von Juan-Pablo Dabdoub und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study explores collaborative governance in highereducation residential centers as a means to promote character development. Its aim is to analyze how this practice is designed and implemented, the challenges it faces, and the opportunities it offers. A mixed-methods questionnaire was administered to directors of 35 centers across six countries. Results show that, although collaborative governance is common, it rarely relies on evidence-based pedagogical models or systematic assessment. Findings reveal training gaps, limited student participation in key decisions, and opportunities to strengthen character development through intentional, research-informed governance design.
Zitieren
APA
Dabdoub, J., Rodríguez-Salaverría, A., & Berkowitz, M. (2026). Collaborative governance in higher-education residential centers: An exploratory mixed-methods study on character development potential. Estudios sobre Educación. https://doi.org/10.15581/004.52.004
Vancouver
Dabdoub J, Rodríguez-Salaverría A, Berkowitz M. Collaborative governance in higher-education residential centers: An exploratory mixed-methods study on character development potential. Estudios sobre Educación. 2026. doi:10.15581/004.52.004
BibTeX
@article{Dabdoub2026,
author = {Dabdoub, Juan-Pablo and Rodríguez-Salaverría, Aitor and Berkowitz, Marvin},
title = {Collaborative governance in higher-education residential centers: An exploratory mixed-methods study on character development potential},
journal = {Estudios sobre Educación},
year = {2026},
doi = {10.15581/004.52.004}
}
EUVIMED